{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:19:46Z","timestamp":1779164386931,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ecl.2024.01.004","type":"journal-article","created":{"date-parts":[[2024,2,18]],"date-time":"2024-02-18T01:10:42Z","timestamp":1708218642000},"page":"229-238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Treatment of Central Precocious Puberty with a Focus on Girls"],"prefix":"10.1016","volume":"53","author":[{"given":"Kanthi","family":"Bangalore Krishna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen O.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica A.","family":"Eugster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ecl.2024.01.004_bib1","first-page":"940","article-title":"Gonadotropin-releasing hormone pulse generator activity during pubertal transition in girls: pulsatile and diurnal patterns of circulating gonadotropins","volume":"76","author":"Apter","year":"1993","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2024.01.004_bib2","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1542\/peds.2012-3773","article-title":"Onset of breast development in a longitudinal cohort","volume":"132","author":"Biro","year":"2013","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.ecl.2024.01.004_bib3","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jpag.2018.05.002","article-title":"Age of Menarche in a Longitudinal US Cohort","volume":"31","author":"Biro","year":"2018","journal-title":"J\u00a0Pediatr Adolesc Gynecol"},{"issue":"6","key":"10.1016\/j.ecl.2024.01.004_bib4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1159\/000501336","article-title":"Use of gonadotropin-releasing hormone analogs in children: update by an international consortium","volume":"91","author":"Bangalore Krishna","year":"2019","journal-title":"Horm Res Paediatr"},{"issue":"2","key":"10.1016\/j.ecl.2024.01.004_bib5","first-page":"415","article-title":"Unsustained or slowly progressive puberty in young girls: initial presentation and long-term follow-up of 20 untreated patients","volume":"84","author":"Palmert","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2024.01.004_bib6","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1067\/mpd.2001.114476","article-title":"Impact of timing of pubertal maturation on growth in black and white female adolescents: The National Heart, Lung, and Blood Institute Growth and Health Study","volume":"138","author":"Biro","year":"2001","journal-title":"J\u00a0Pediatr"},{"issue":"6","key":"10.1016\/j.ecl.2024.01.004_bib7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1530\/EJE-18-0473","article-title":"GnRH analog is ineffective in increasing adult height in girls with puberty onset after 7 years of age: a systematic review and meta-analysis","volume":"179","author":"Franzini","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.ecl.2024.01.004_bib8","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-1703","article-title":"Age at menarche, depression, and antisocial behavior in adulthood","volume":"141","author":"Mendle","year":"2018","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.ecl.2024.01.004_bib9","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jadohealth.2019.06.004","article-title":"Early menarche and internalizing and externalizing in adulthood: explaining the persistence of effects","volume":"65","author":"Mendle","year":"2019","journal-title":"J\u00a0Adolesc Health"},{"issue":"4368","key":"10.1016\/j.ecl.2024.01.004_bib10","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1126\/science.100883","article-title":"Hypophysial responses to continuous and intermittent delivery of hypopthalamic gonadotropin-releasing hormone","volume":"202","author":"Belchetz","year":"1978","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.ecl.2024.01.004_bib11","first-page":"1697","article-title":"Efficacy and safety of histrelin subdermal implant in children with central precocious puberty: a multicenter trial","volume":"92","author":"Eugster","year":"2007","journal-title":"JClinEndocrinolMetab"},{"issue":"4","key":"10.1016\/j.ecl.2024.01.004_bib12","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jpeds.2013.05.033","article-title":"A\u00a0single histrelin implant is effective for 2 years for treatment of central precocious puberty","volume":"163","author":"Lewis","year":"2013","journal-title":"J\u00a0Pediatr"},{"issue":"3","key":"10.1016\/j.ecl.2024.01.004_bib13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1515\/jpem-2022-0557","article-title":"Long-term experience with the use of a single histrelin implant beyond one year in patients with central precocious puberty","volume":"36","author":"Ray","year":"2023","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ecl.2024.01.004_bib14","first-page":"3153","article-title":"36-month treatment experience of two doses of leuprolide acetate 3-month depot for children with central precocious puberty","volume":"99","author":"Lee","year":"2014","journal-title":"JClinEndocrinolMetab"},{"issue":"6","key":"10.1016\/j.ecl.2024.01.004_bib15","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1210\/jc.2013-1024","article-title":"Treatment and outcomes of precocious puberty: an update","volume":"98","author":"Fuqua","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2024.01.004_bib16","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000456545","article-title":"Meta-Analysis of Paediatric Patients with Central Precocious Puberty Treated with Intramuscular Triptorelin 11.25\u00a0mg 3-Month Prolonged-Release Formulation","volume":"87","author":"Durand","year":"2017","journal-title":"Horm Res Paediatr"},{"issue":"11","key":"10.1016\/j.ecl.2024.01.004_bib17","first-page":"1241","article-title":"Efficacy and safety of triptorelin 6-month formulation in patients with central precocious puberty","volume":"29","author":"Klein","year":"2016","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ecl.2024.01.004_bib18","doi-asserted-by":"crossref","first-page":"e3660","DOI":"10.1210\/clinem\/dgaa479","article-title":"Phase 3 trial of a small-volume subcutaneous 6-month duration leuprolide acetate treatment for central precocious puberty","volume":"105","author":"Klein","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.ecl.2024.01.004_bib19","doi-asserted-by":"crossref","first-page":"bvad071","DOI":"10.1210\/jendso\/bvad071","article-title":"Efficacy and safety of leuprolide acetate 6-month depot for the treatment of central precocious puberty: a phase 3 study","volume":"7","author":"Klein","year":"2023","journal-title":"J\u00a0Endocr Soc"},{"issue":"4","key":"10.1016\/j.ecl.2024.01.004_bib20","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.beem.2018.05.008","article-title":"Central precocious puberty: From genetics to treatment","volume":"32","author":"Aguirre","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"issue":"4","key":"10.1016\/j.ecl.2024.01.004_bib21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s40272-015-0130-8","article-title":"Central Precocious Puberty: Update on Diagnosis and Treatment","volume":"17","author":"Chen","year":"2015","journal-title":"Pediatr Drugs"},{"issue":"10","key":"10.1016\/j.ecl.2024.01.004_bib22","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.clinthera.2010.09.009","article-title":"Sterile abscess formation in response to two separate branded long-acting gonadotropin-releasing hormone agonists","volume":"32","author":"Miller","year":"2010","journal-title":"Clin Therapeut"},{"issue":"2","key":"10.1016\/j.ecl.2024.01.004_bib23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/17446651.2019.1575726","article-title":"Update on central precocious puberty: from etiologies to outcomes","volume":"14","author":"Cantas-Orsdemir","year":"2019","journal-title":"Expert Rev Endocrino"},{"issue":"3","key":"10.1016\/j.ecl.2024.01.004_bib24","first-page":"345","article-title":"Long-term effects and significant Adverse Drug Reactions (ADRs) associated with the use of Gonadotropin-Releasing Hormone analogs (GnRHa) for central precocious puberty: a brief review of literature","volume":"90","author":"De Sanctis","year":"2019","journal-title":"Acta Biomed"},{"key":"10.1016\/j.ecl.2024.01.004_bib25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jpeds.2021.12.030","article-title":"Gonadotropin-releasing hormone analogs for treatment of central precocious puberty in children younger than 2 years of age","volume":"244","author":"Gohil","year":"2022","journal-title":"J\u00a0Pediatr Urol"},{"issue":"5","key":"10.1016\/j.ecl.2024.01.004_bib26","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1210\/js.2019-00036","article-title":"Treatment of central precocious puberty","volume":"3","author":"Eugster","year":"2019","journal-title":"J\u00a0Endocr Soc"},{"issue":"1","key":"10.1016\/j.ecl.2024.01.004_bib27","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/s41598-023-28602-3","article-title":"Effect of gonadotropin-releasing hormone agonist monotherapy and combination therapy with growth hormone on final adult height in girls with central precocious puberty","volume":"13","author":"Cho","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.ecl.2024.01.004_bib28","doi-asserted-by":"crossref","first-page":"678797","DOI":"10.3389\/fendo.2021.678797","article-title":"GnRHa\/stanozolol combined therapy maintains normal bone growth in central precocious puberty","volume":"12","author":"Zhu","year":"2021","journal-title":"Front Endocrinol"},{"issue":"4","key":"10.1016\/j.ecl.2024.01.004_bib29","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1210\/jc.2005-1693","article-title":"Final height in girls with central idiopathic precocious puberty treated with gonadotropin-releasing hormone analog and oxandrolone","volume":"91","author":"Vottero","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ecl.2024.01.004_bib30","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s40618-016-0486-9","article-title":"Effects and safety of combination therapy with gonadotropin-releasing hormone analogue and growth hormone in girls with idiopathic central precocious puberty: a meta-analysis","volume":"39","author":"Liu","year":"2016","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"6","key":"10.1016\/j.ecl.2024.01.004_bib31","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1515\/jpem-2021-0114","article-title":"Importance of individualizing treatment decisions in girls with central precocious puberty when initiating treatment after age 7 years or continuing beyond a chronological age of 10 years or a bone age of 12 years","volume":"34","author":"Vargas Trujillo","year":"2021","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"key":"10.1016\/j.ecl.2024.01.004_bib32","doi-asserted-by":"crossref","first-page":"398639","DOI":"10.1186\/1687-9856-2010-398639","article-title":"Leuprolide acetate 1-month depot for central precocious puberty: hormonal suppression and recovery","volume":"2010","author":"Neely","year":"2010","journal-title":"Int J Pediatr Endocrinol"},{"issue":"1","key":"10.1016\/j.ecl.2024.01.004_bib33","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1687-9856-2013-20","article-title":"Random unstimulated pediatric luteinizing hormone levels are not reliable in the assessment of pubertal suppression during histrelin implant therapy","volume":"2013","author":"Neely","year":"2013","journal-title":"Int J Pediatr Endocrinol"},{"issue":"3","key":"10.1016\/j.ecl.2024.01.004_bib34","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jpeds.2012.08.038","article-title":"Random luteinizing hormone often remains pubertal in children treated with the histrelin implant for central precocious puberty","volume":"162","author":"Lewis","year":"2013","journal-title":"J\u00a0Pediatr"},{"issue":"3","key":"10.1016\/j.ecl.2024.01.004_bib35","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1515\/jpem-2022-0476","article-title":"Using change in predicted adult height during GnRH agonist treatment for individualized treatment decisions in girls with central precocious puberty","volume":"36","author":"Trujillo","year":"2023","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"issue":"27","key":"10.1016\/j.ecl.2024.01.004_bib36","doi-asserted-by":"crossref","first-page":"e260","DOI":"10.1097\/MD.0000000000000260","article-title":"Gonadotropin releasing hormone agonist treatment to increase final stature in children with precocious puberty: a meta-analysis","volume":"93","author":"Li","year":"2014","journal-title":"Medicine (Baltim)"},{"issue":"4","key":"10.1016\/j.ecl.2024.01.004_bib37","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.jpeds.2013.12.009","article-title":"Resumption of puberty in girls and boys following removal of the histrelin implant","volume":"164","author":"Fisher","year":"2014","journal-title":"J\u00a0Pediatr"},{"issue":"3","key":"10.1016\/j.ecl.2024.01.004_bib38","first-page":"306","article-title":"Review of outcomes after cessation of gonadotropin-releasing hormone agonist treatment of girls with precocious puberty","volume":"11","author":"Thornton","year":"2014","journal-title":"Pediatr Endocrinol Rev"},{"issue":"5","key":"10.1016\/j.ecl.2024.01.004_bib39","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1210\/js.2019-00036","article-title":"Treatment of Central Precocious Puberty","volume":"3","author":"Eugster","year":"2019","journal-title":"Journal of the Endocrine Society"},{"issue":"4","key":"10.1016\/j.ecl.2024.01.004_bib40","doi-asserted-by":"crossref","first-page":"e752","DOI":"10.1542\/peds.2008-1783","article-title":"Consensus statement on the use of gonadotropin-releasing hormone analogs in children","volume":"123","author":"Carel","year":"2009","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.ecl.2024.01.004_bib41","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1530\/EJE-15-0590","article-title":"Management of endocrine disease: Long-term outcomes of the treatment of central precocious puberty","volume":"174","author":"Guaraldi","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.ecl.2024.01.004_bib42","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2024.01.004_bib43","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1210\/jc.2006-2012","article-title":"Clinical review: Identifying children at risk for polycystic ovary syndrome","volume":"92","author":"Rosenfield","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2024.01.004_bib44","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1530\/eje.1.01975","article-title":"Outcome after depot gonadotrophin-releasing hormone agonist treatment for central precocious puberty: effects on body mass index and final height","volume":"153","author":"Traggiai","year":"2005","journal-title":"Eur J Endocrinol"},{"issue":"5\u20136","key":"10.1016\/j.ecl.2024.01.004_bib45","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1159\/000346145","article-title":"Treatment with gonadotropin-releasing hormone analogues: different impact on body weight in normal-weight and overweight children","volume":"78","author":"Wolters","year":"2012","journal-title":"Horm Res Paediatr"},{"issue":"12","key":"10.1016\/j.ecl.2024.01.004_bib46","first-page":"4480","article-title":"Is obesity an outcome of gonadotropin-releasing hormone agonist administration? Analysis of growth and body composition in 110 patients with central precocious puberty","volume":"84","author":"Palmert","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2024.01.004_bib47","first-page":"370","article-title":"Bone mineral density and body composition before and during treatment with gonadotropin-releasing hormone agonist in children with central precocious and early puberty","volume":"83","author":"Boot","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2024.01.004_bib48","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1210\/jc.2014-3748","article-title":"Treated and untreated women with idiopathic precocious puberty: BMI evolution, metabolic outcome, and general health between third and fifth decades","volume":"100","author":"Lazar","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.ecl.2024.01.004_bib49","first-page":"4583","article-title":"Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function","volume":"84","author":"Heger","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"23","key":"10.1016\/j.ecl.2024.01.004_bib50","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2004325","article-title":"Oral relugolix for androgen-deprivation therapy in advanced prostate cancer","volume":"382","author":"Shore","year":"2020","journal-title":"N\u00a0Engl J Med"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852924000069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852924000069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T22:11:51Z","timestamp":1719267111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852924000069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0889852924000069"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2024.01.004","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Central Precocious Puberty with a Focus on Girls","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2024.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}